Caseware UK (AP4) 2024.0.164 2024.0.164 2024-09-302024-09-302025-05-21dormant2023-10-01true11falsefalse 01751736 2023-10-01 2024-09-30 01751736 2022-10-01 2023-09-30 01751736 2024-09-30 01751736 2023-09-30 01751736 c:Director1 2023-10-01 2024-09-30 01751736 c:EntityHasNeverTraded 2023-10-01 2024-09-30 01751736 c:AuditExempt-NoAccountantsReport 2023-10-01 2024-09-30 01751736 c:FullAccounts 2023-10-01 2024-09-30 01751736 c:PrivateLimitedCompanyLtd 2023-10-01 2024-09-30 01751736 c:Micro-entities 2023-10-01 2024-09-30 01751736 d:PoundSterling 2023-10-01 2024-09-30 iso4217:GBP xbrli:pure
Registered number: 01751736






ESSLAB LIMITED
UNAUDITED
FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 SEPTEMBER 2024










img0829.png

 
ESSLAB LIMITED
REGISTERED NUMBER:01751736

BALANCE SHEET
AS AT 30 SEPTEMBER 2024

2024
2023
£
£


Current assets
2
2


Net assets
2
2



Capital and reserves
2
2


Notes


General information

Esslab Limited is a private company limited by shares, incorporated in England and Wales. Its registered office is 356-358 Prince Avenue, Westcliff-on-Sea, Essex, SS0 0NF.
The company is dormant and has not traded during the year.


Average number of employees

The average monthly number of employees, including directors, during the year was 1 (2023 - 1).


Director's confirmations

The Company was entitled to exemption from audit under section 480 of the Companies Act 2006.

The members have not required the Company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

These financial statements have been prepared in accordance with the provisions applicable to entities subject to the micro-entities' regime.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf by: 



C J Marshall
Director

Date: 21 May 2025

Page 1